Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mist Pharmaceuticals is a specialty pharmaceutical company and a subsidiary of Amneal Pharmaceuticals, focused on the commercialization of branded and generic products. The company is best known for its flagship product, Unithroid (levothyroxine sodium), which is used to treat hypothyroidism and manage thyroid-stimulating hormone levels. Mist Pharmaceuticals operates by identifying niche market opportunities and leveraging the robust manufacturing and R&D capabilities of its parent organization. The company maintains a lean operational structure while providing high-quality, affordable medication options to patients in the United States. Its portfolio primarily targets endocrinology and other specialty therapeutic areas. Mist was founded by the Patel brothers and remains a key component of Amneal's specialty business segment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mist Biopharma.